Nanocarrier-based drug delivery systems for precision oncology: pharmaceutical design, tumor targeting, and clinical translation

Journal of Pharmaceutical Investigation · Published 2026-08-05 · DOI 10.1007/s40005-026-00823-4

Authors (2)

Aziz Ullah, Byoung-San Moon

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Ullah, A., Moon, B. (2026). Nanocarrier-based drug delivery systems for precision oncology: pharmaceutical design, tumor targeting, and clinical translation. Journal of Pharmaceutical Investigation. https://doi.org/10.1007/s40005-026-00823-4

Related articles

• Next-generation nanocarriers for precision antitumor therapy: from passive targeting to intelligent response · Exploration of Targeted Anti-tumor Therapy · 2025 · Cites or is cited by this article
• Dose optimization of omadacycline for the treatment of nontuberculous mycobacterial pulmonary disease (NTM-PD) using a physiologically based pharmacokinetic modeling approach · Journal of Pharmaceutical Investigation · 2025 · Same journal
• Architecture-driven optimization of nanocarriers for pH-responsive drug delivery · Journal of Pharmaceutical Investigation · 2026 · Same journal
• From meal to medicine: exploring the roots and consequences of drug-food effects · Journal of Pharmaceutical Investigation · 2026 · Same journal
• Antimicrobial and thermostabilizing properties of a novel surfactant on different bacterial species · Journal of Pharmaceutical Investigation · 2026 · Same journal
• Mechanistic insights into the self-assembly and cellular uptake of thermoresponsive pNIPAM-grafted hyaluronic acid nanogels · Journal of Pharmaceutical Investigation · 2025 · Same journal
• Exploring anti-integrin α6 antibody and transferrin-decorated dual drug-loaded liposomes as a promising nanoplatform for glioblastoma therapy: a preclinical approach · Journal of Pharmaceutical Investigation · 2025 · Same journal
• Necessity of considering sex factors in the clinical application of transdermal formulations · Journal of Pharmaceutical Investigation · 2025 · Same journal
• Immune-chemo combination therapy using doxorubicin/viral epitope Pluronic nanoparticles · Journal of Pharmaceutical Investigation · 2025 · Same journal
• Unveiling the treatment potential of irinotecan-loaded biopolymeric nanocarrier system in skin cancer via targeting CD44 receptors · Journal of Pharmaceutical Investigation · 2025 · Same journal